Tian Feng, Gao Xuejin, Wu Chao, Zhang Li, Xia Xianfeng, Wang Xinying
Research Institute of General Surgery, Jinling Hospital, Medical School of Nanjing University, Nanjing, Jiangsu Province, China.
Department of General Surgery, Jinling Hospital, South Medical University, Guangdong Province, China.
Asia Pac J Clin Nutr. 2017 Jan;26(1):11-19. doi: 10.6133/apjcn.102015.11.
Here we systematically reviewed and quantitatively analyzed randomized controlled trials (RCTs) to compare the important initial outcomes of critically ill adults receiving low- and highenergy enteral nutrition.
RCTs comparing low- and high-energy supplementation in critically ill adults receiving enteral nutrition admitted to the intensive care unit for an expected stay of >48 h were included. Abstracts submitted to major scientific meetings were included and the primary endpoint was mortality. The risk ratio (RR) and weighted mean difference (WMD) with 95% confidence intervals (CIs) were the effect measures.
Eleven RCTs (3,212 patients) were included. The groups did not differ significantly in mortality (RR, 0.94; 95% CI, 0.80-1.11; p=0.47), infections morbidity (RR 1.09; 95% CI 0.95-1.26; p=0.23), pneumonia morbidity (RR 1.04; 95% CI 0.88-1.23; p=0.68), hospital length of stay (WMD -0.27; 95% CI -3.21 to 3.76; p=0.88), intensive care unit length of stay (WMD -0.32; 95% CI, -1.81 to 1.16; p=0.46), mechanical ventilation days (WMD -0.30; 95% CI-1.42 to 0.82; p=0.60). The incidence of gastrointestinal intolerance was significantly lower in the low-energy group (RR 0.79; 95% CI 0.65-0.97; p<0.05).
The initial administration of low- versus high-energy supplements did not impact clinical outcomes except for gastrointestinal intolerance in non-malnourished critically ill patients receiving enteral nutrition. The initial administration of highrather than low-energy may benefit these patients by reducing infections, but this effect might actually be attributable to the concomitant high protein intake.
在此,我们系统回顾并定量分析了随机对照试验(RCT),以比较接受低能量和高能量肠内营养的成年危重症患者的重要初始结局。
纳入了对入住重症监护病房、预计住院时间超过48小时且接受肠内营养的成年危重症患者进行低能量与高能量补充比较的随机对照试验。已提交至主要科学会议的摘要也被纳入,主要终点为死亡率。风险比(RR)和加权平均差(WMD)及其95%置信区间(CI)为效应测量指标。
纳入了11项随机对照试验(3212例患者)。两组在死亡率(RR,0.94;95%CI,0.80 - 1.11;p = 0.47)、感染发病率(RR 1.09;95%CI 0.95 - 1.26;p = 0.23)、肺炎发病率(RR 1.04;95%CI 0.88 - 1.23;p = 0.68)、住院时间(WMD -0.27;95%CI -3.21至3.76;p = 0.88)、重症监护病房住院时间(WMD -0.32;95%CI,-1.81至1.16;p = 0.46)、机械通气天数(WMD -0.30;95%CI -1.42至0.82;p = 0.60)方面无显著差异。低能量组胃肠道不耐受的发生率显著更低(RR 0.79;95%CI 0.65 - 0.97;p < 0.05)。
对于接受肠内营养的非营养不良成年危重症患者,初始给予低能量与高能量补充剂除了胃肠道不耐受外,对临床结局无影响。初始给予高能量而非低能量可能通过减少感染使这些患者获益,但这种效应实际上可能归因于同时摄入的高蛋白。